Global Adrenocortical Carcinoma Treatment Market 2018-2024: Opportunities, Future Trends, Growing Demand, Analysis, Forecast & Industry Developments

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Aug-2018   |    Format :PDF   |    Number of Pages : 99
This report focuses on the global Adrenocortical Carcinoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adrenocortical Carcinoma Treatment development in United States, Europe and China.

Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. The causes of primary adrenocortical carcinoma are unknown. However adrenocortical carcinoma can also be secondary cancer. A secondary cancer is what happens when another form of cancer spreads to the adrenal glands. Adrenocortical carcinoma can occur at any age, but there is a bimodal distribution with a first peak at childhood between 1–6 years old and the second peak in the fourth to the fifth decade of life. During the past decade, collaborative efforts have been made to improve the ACC treatment. 
Some of the key factors that are driving the adrenocortical carcinoma treatment market are increasing the prevalence of cancer, rising government involvement, increasing funding from various government and non-government organizations. Also, ethical acceptance of adrenocortical carcinoma treatment and high unmet needs in some regions are driving the adrenocortical carcinoma treatment market. However, less awareness and high cost involved in treatment are restraining the global adrenocortical carcinoma treatment market. Also, the introduction of generic drugs in some countries is restraining the growth of adrenocortical carcinoma treatment market. Also, despite the high cost involved in R&D, pharmaceutical companies are showing increased interest in this field. This is expected to offer good potential for adrenocortical carcinoma treatment market.
In 2017, the global Adrenocortical Carcinoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
    ArQule
    EnGeneIC
    Exelixis
    Merck
    Millendo Therapeutics
    Orphagen Pharmaceuticals
    ...

Market segment by Type, the product can be split into
    Localized Adrenocortical Carcinoma
    Metastatic Adrenocortical Carcinoma

Market segment by Application, split into
    Hospitals
    Ambulatory Surgical Centers
    Clinics
    Cancer Research Institutes

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Adrenocortical Carcinoma Treatment status, future forecast, growth opportunity, key market and key players.
    To present the Adrenocortical Carcinoma Treatment development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Adrenocortical Carcinoma Treatment are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Adrenocortical Carcinoma Treatment Market Size Growth Rate by Type (2013-2025)
        1.4.2 Localized Adrenocortical Carcinoma
        1.4.3 Metastatic Adrenocortical Carcinoma
    1.5 Market by Application
        1.5.1 Global Adrenocortical Carcinoma Treatment Market Share by Application (2013-2025)
        1.5.2 Hospitals
        1.5.3 Ambulatory Surgical Centers
        1.5.4 Clinics
        1.5.5 Cancer Research Institutes
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Adrenocortical Carcinoma Treatment Market Size
    2.2 Adrenocortical Carcinoma Treatment Growth Trends by Regions
        2.2.1 Adrenocortical Carcinoma Treatment Market Size by Regions (2013-2025)
        2.2.2 Adrenocortical Carcinoma Treatment Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Adrenocortical Carcinoma Treatment Market Size by Manufacturers
        3.1.1 Global Adrenocortical Carcinoma Treatment Revenue by Manufacturers (2013-2018)
        3.1.2 Global Adrenocortical Carcinoma Treatment Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Adrenocortical Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
    3.2 Adrenocortical Carcinoma Treatment Key Players Head office and Area Served
    3.3 Key Players Adrenocortical Carcinoma Treatment Product/Solution/Service
    3.4 Date of Enter into Adrenocortical Carcinoma Treatment Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Adrenocortical Carcinoma Treatment Market Size by Type (2013-2018)
    4.2 Global Adrenocortical Carcinoma Treatment Market Size by Application (2013-2018)

5 United States
    5.1 United States Adrenocortical Carcinoma Treatment Market Size (2013-2018)
    5.2 Adrenocortical Carcinoma Treatment Key Players in United States
    5.3 United States Adrenocortical Carcinoma Treatment Market Size by Type
    5.4 United States Adrenocortical Carcinoma Treatment Market Size by Application

6 Europe
    6.1 Europe Adrenocortical Carcinoma Treatment Market Size (2013-2018)
    6.2 Adrenocortical Carcinoma Treatment Key Players in Europe
    6.3 Europe Adrenocortical Carcinoma Treatment Market Size by Type
    6.4 Europe Adrenocortical Carcinoma Treatment Market Size by Application

7 China
    7.1 China Adrenocortical Carcinoma Treatment Market Size (2013-2018)
    7.2 Adrenocortical Carcinoma Treatment Key Players in China
    7.3 China Adrenocortical Carcinoma Treatment Market Size by Type
    7.4 China Adrenocortical Carcinoma Treatment Market Size by Application

8 Japan
    8.1 Japan Adrenocortical Carcinoma Treatment Market Size (2013-2018)
    8.2 Adrenocortical Carcinoma Treatment Key Players in Japan
    8.3 Japan Adrenocortical Carcinoma Treatment Market Size by Type
    8.4 Japan Adrenocortical Carcinoma Treatment Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Adrenocortical Carcinoma Treatment Market Size (2013-2018)
    9.2 Adrenocortical Carcinoma Treatment Key Players in Southeast Asia
    9.3 Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Type
    9.4 Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Application

10 India
    10.1 India Adrenocortical Carcinoma Treatment Market Size (2013-2018)
    10.2 Adrenocortical Carcinoma Treatment Key Players in India
    10.3 India Adrenocortical Carcinoma Treatment Market Size by Type
    10.4 India Adrenocortical Carcinoma Treatment Market Size by Application

11 Central & South America
    11.1 Central & South America Adrenocortical Carcinoma Treatment Market Size (2013-2018)
    11.2 Adrenocortical Carcinoma Treatment Key Players in Central & South America
    11.3 Central & South America Adrenocortical Carcinoma Treatment Market Size by Type
    11.4 Central & South America Adrenocortical Carcinoma Treatment Market Size by Application

12 International Players Profiles
    12.1 ArQule
        12.1.1 ArQule Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Adrenocortical Carcinoma Treatment Introduction
        12.1.4 ArQule Revenue in Adrenocortical Carcinoma Treatment Business (2013-2018)
        12.1.5 ArQule Recent Development
    12.2 EnGeneIC
        12.2.1 EnGeneIC Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Adrenocortical Carcinoma Treatment Introduction
        12.2.4 EnGeneIC Revenue in Adrenocortical Carcinoma Treatment Business (2013-2018)
        12.2.5 EnGeneIC Recent Development
    12.3 Exelixis
        12.3.1 Exelixis Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Adrenocortical Carcinoma Treatment Introduction
        12.3.4 Exelixis Revenue in Adrenocortical Carcinoma Treatment Business (2013-2018)
        12.3.5 Exelixis Recent Development
    12.4 Merck
        12.4.1 Merck Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Adrenocortical Carcinoma Treatment Introduction
        12.4.4 Merck Revenue in Adrenocortical Carcinoma Treatment Business (2013-2018)
        12.4.5 Merck Recent Development
    12.5 Millendo Therapeutics
        12.5.1 Millendo Therapeutics Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Adrenocortical Carcinoma Treatment Introduction
        12.5.4 Millendo Therapeutics Revenue in Adrenocortical Carcinoma Treatment Business (2013-2018)
        12.5.5 Millendo Therapeutics Recent Development
    12.6 Orphagen Pharmaceuticals
        12.6.1 Orphagen Pharmaceuticals Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Adrenocortical Carcinoma Treatment Introduction
        12.6.4 Orphagen Pharmaceuticals Revenue in Adrenocortical Carcinoma Treatment Business (2013-2018)
        12.6.5 Orphagen Pharmaceuticals Recent Development

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details



List of Tables and Figures

    Table Adrenocortical Carcinoma Treatment Key Market Segments
    Table Key Players Adrenocortical Carcinoma Treatment Covered
    Table Global Adrenocortical Carcinoma Treatment Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Adrenocortical Carcinoma Treatment Market Size Market Share by Type 2013-2025
    Figure Localized Adrenocortical Carcinoma Figures
    Table Key Players of Localized Adrenocortical Carcinoma
    Figure Metastatic Adrenocortical Carcinoma Figures
    Table Key Players of Metastatic Adrenocortical Carcinoma
    Table Global Adrenocortical Carcinoma Treatment Market Size Growth by Application 2013-2025 (Million US$)
    Figure Hospitals Case Studies
    Figure Ambulatory Surgical Centers Case Studies
    Figure Clinics Case Studies
    Figure Cancer Research Institutes Case Studies
    Figure Adrenocortical Carcinoma Treatment Report Years Considered
    Table Global Adrenocortical Carcinoma Treatment Market Size 2013-2025 (Million US$)
    Figure Global Adrenocortical Carcinoma Treatment Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Adrenocortical Carcinoma Treatment Market Size by Regions 2013-2025 (Million US$)
    Table Global Adrenocortical Carcinoma Treatment Market Size by Regions 2013-2018 (Million US$)
    Table Global Adrenocortical Carcinoma Treatment Market Share by Regions 2013-2018
    Figure Global Adrenocortical Carcinoma Treatment Market Share by Regions 2013-2018
    Figure Global Adrenocortical Carcinoma Treatment Market Share by Regions 2018
    Table Market Top Trends
    Table Global Adrenocortical Carcinoma Treatment Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Adrenocortical Carcinoma Treatment Market Share by Manufacturers (2013-2018)
    Figure Global Adrenocortical Carcinoma Treatment Market Share by Manufacturers in 2018
    Table Global Adrenocortical Carcinoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Adrenocortical Carcinoma Treatment Product/Solution/Service
    Table Date of Enter into Adrenocortical Carcinoma Treatment Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Adrenocortical Carcinoma Treatment Market Size by Type (2013-2018) (Million US$)
    Table Global Adrenocortical Carcinoma Treatment Market Size Share by Type (2013-2018)
    Figure Global Adrenocortical Carcinoma Treatment Market Size Market Share by Type (2013-2018)
    Table Global Adrenocortical Carcinoma Treatment Market Size by Application (2013-2018) (Million US$)
    Table Global Adrenocortical Carcinoma Treatment Market Size Share by Application (2013-2018)
    Figure Global Adrenocortical Carcinoma Treatment Market Size Market Share by Application (2013-2018)
    Figure Global Adrenocortical Carcinoma Treatment Revenue Market Share by Application in 2017
    Figure United States Adrenocortical Carcinoma Treatment Market Size 2013-2018 (Million US$)
    Table United States Key Players Adrenocortical Carcinoma Treatment Revenue (2017-2018) (Million US$)
    Table United States Key Players Adrenocortical Carcinoma Treatment Market Share (2017-2018)
    Table United States Adrenocortical Carcinoma Treatment Market Size by Type (2013-2018) (Million US$)
    Table United States Adrenocortical Carcinoma Treatment Market Share by Type (2013-2018)
    Table United States Adrenocortical Carcinoma Treatment Market Size by Application (2013-2018) (Million US$)
    Table United States Adrenocortical Carcinoma Treatment Market Share by Application (2013-2018)
    Figure Europe Adrenocortical Carcinoma Treatment Market Size 2013-2018 (Million US$)
    Table Europe Key Players Adrenocortical Carcinoma Treatment Revenue (2017-2018) (Million US$)
    Table Europe Key Players Adrenocortical Carcinoma Treatment Market Share (2017-2018)
    Table Europe Adrenocortical Carcinoma Treatment Market Size by Type (2013-2018) (Million US$)
    Table Europe Adrenocortical Carcinoma Treatment Market Share by Type (2013-2018)
    Table Europe Adrenocortical Carcinoma Treatment Market Size by Application (2013-2018) (Million US$)
    Table Europe Adrenocortical Carcinoma Treatment Market Share by Application (2013-2018)
    Figure China Adrenocortical Carcinoma Treatment Market Size 2013-2018 (Million US$)
    Table China Key Players Adrenocortical Carcinoma Treatment Revenue (2017-2018) (Million US$)
    Table China Key Players Adrenocortical Carcinoma Treatment Market Share (2017-2018)
    Table China Adrenocortical Carcinoma Treatment Market Size by Type (2013-2018) (Million US$)
    Table China Adrenocortical Carcinoma Treatment Market Share by Type (2013-2018)
    Table China Adrenocortical Carcinoma Treatment Market Size by Application (2013-2018) (Million US$)
    Table China Adrenocortical Carcinoma Treatment Market Share by Application (2013-2018)
    Figure Japan Adrenocortical Carcinoma Treatment Market Size 2013-2018 (Million US$)
    Table Japan Key Players Adrenocortical Carcinoma Treatment Revenue (2017-2018) (Million US$)
    Table Japan Key Players Adrenocortical Carcinoma Treatment Market Share (2017-2018)
    Table Japan Adrenocortical Carcinoma Treatment Market Size by Type (2013-2018) (Million US$)
    Table Japan Adrenocortical Carcinoma Treatment Market Share by Type (2013-2018)
    Table Japan Adrenocortical Carcinoma Treatment Market Size by Application (2013-2018) (Million US$)
    Table Japan Adrenocortical Carcinoma Treatment Market Share by Application (2013-2018)
    Figure Southeast Asia Adrenocortical Carcinoma Treatment Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Adrenocortical Carcinoma Treatment Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Adrenocortical Carcinoma Treatment Market Share (2017-2018)
    Table Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Adrenocortical Carcinoma Treatment Market Share by Type (2013-2018)
    Table Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Adrenocortical Carcinoma Treatment Market Share by Application (2013-2018)
    Figure India Adrenocortical Carcinoma Treatment Market Size 2013-2018 (Million US$)
    Table India Key Players Adrenocortical Carcinoma Treatment Revenue (2017-2018) (Million US$)
    Table India Key Players Adrenocortical Carcinoma Treatment Market Share (2017-2018)
    Table India Adrenocortical Carcinoma Treatment Market Size by Type (2013-2018) (Million US$)
    Table India Adrenocortical Carcinoma Treatment Market Share by Type (2013-2018)
    Table India Adrenocortical Carcinoma Treatment Market Size by Application (2013-2018) (Million US$)
    Table India Adrenocortical Carcinoma Treatment Market Share by Application (2013-2018)
    Figure Central & South America Adrenocortical Carcinoma Treatment Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Adrenocortical Carcinoma Treatment Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Adrenocortical Carcinoma Treatment Market Share (2017-2018)
    Table Central & South America Adrenocortical Carcinoma Treatment Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Adrenocortical Carcinoma Treatment Market Share by Type (2013-2018)
    Table Central & South America Adrenocortical Carcinoma Treatment Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Adrenocortical Carcinoma Treatment Market Share by Application (2013-2018)
    Table ArQule Company Details
    Table ArQule Revenue in Adrenocortical Carcinoma Treatment Business (2013-2018) (Million US$)
    Figure ArQule Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2013-2018)
    Table ArQule Recent Development
    Table EnGeneIC Company Details
    Table EnGeneIC Revenue in Adrenocortical Carcinoma Treatment Business (2013-2018)(Million US$)
    Figure EnGeneIC Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2013-2018)
    Table EnGeneIC Recent Development
    Table Exelixis Company Details
    Table Exelixis Revenue in Adrenocortical Carcinoma Treatment Business (2013-2018)(Million US$)
    Figure Exelixis Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2013-2018)
    Table Exelixis Recent Development
    Table Merck Company Details
    Table Merck Revenue in Adrenocortical Carcinoma Treatment Business (2013-2018)(Million US$)
    Figure Merck Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2013-2018)
    Table Merck Recent Development
    Table Millendo Therapeutics Company Details
    Table Millendo Therapeutics Revenue in Adrenocortical Carcinoma Treatment Business (2013-2018)(Million US$)
    Figure Millendo Therapeutics Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2013-2018)
    Table Millendo Therapeutics Recent Development
    Table Orphagen Pharmaceuticals Company Details
    Table Orphagen Pharmaceuticals Revenue in Adrenocortical Carcinoma Treatment Business (2013-2018)(Million US$)
    Figure Orphagen Pharmaceuticals Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2013-2018)
    Table Orphagen Pharmaceuticals Recent Development
    Table Global Adrenocortical Carcinoma Treatment Market Size by Regions (Million US$) 2018-2025
    Figure Global Adrenocortical Carcinoma Treatment Market Size Share by Regions (2018-2025)
    Figure Global Adrenocortical Carcinoma Treatment Market Size Share by Regions in 2025
    Figure United States Adrenocortical Carcinoma Treatment Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Adrenocortical Carcinoma Treatment Market Size Forecast (2018-2025)(Million USD)
    Figure China Adrenocortical Carcinoma Treatment Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Adrenocortical Carcinoma Treatment Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Adrenocortical Carcinoma Treatment Market Size Forecast (2018-2025)(Million USD)
    Figure India Adrenocortical Carcinoma Treatment Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Adrenocortical Carcinoma Treatment Market Size Forecast (2018-2025)(Million USD)
    Table Global Adrenocortical Carcinoma Treatment Market Size by Product (2018-2025) (Million US$)
    Figure Global Adrenocortical Carcinoma Treatment Market Size by Product (2018-2025)
    Figure Global Adrenocortical Carcinoma Treatment Market Size by Product in 2025
    Table Global Adrenocortical Carcinoma Treatment Market Size by Application (2018-2025) (Million US$)
    Figure Global Adrenocortical Carcinoma Treatment Market Size by Application (2018-2025)
    Figure Global Adrenocortical Carcinoma Treatment Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...